407634-05-3 Usage
Uses
Used in Pharmaceutical Industry:
1-(2-Methoxy-ethyl)-5-oxo-pyrrolidine-3-carboxylic acid is used as a building block for the synthesis of pharmaceuticals due to its versatile chemical structure and reactivity. It serves as a key intermediate in the development of new drugs with potential therapeutic effects.
Used in Agrochemical Industry:
In the agrochemical sector, 1-(2-Methoxy-ethyl)-5-oxo-pyrrolidine-3-carboxylic acid is utilized as a precursor in the synthesis of agrochemicals, contributing to the creation of compounds with pesticidal or herbicidal properties, thereby enhancing crop protection.
Used in Medicinal Applications:
1-(2-Methoxy-ethyl)-5-oxo-pyrrolidine-3-carboxylic acid is employed as an anti-inflammatory agent, leveraging its chemical properties to modulate inflammatory responses and alleviate associated symptoms.
Used in Antiviral Applications:
1-(2-METHOXY-ETHYL)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID also serves as an antiviral agent, potentially inhibiting viral replication or entry into host cells, thus offering a therapeutic approach to combat viral infections.
Used in Anticancer Applications:
1-(2-Methoxy-ethyl)-5-oxo-pyrrolidine-3-carboxylic acid is used in cancer research and treatment, where it may exhibit properties that interfere with cancer cell growth and proliferation, offering a potential avenue for cancer therapy.
Used in Neurodegenerative Disease Treatment:
It has been studied for its potential role in treating neurodegenerative diseases, where it may contribute to the amelioration of disease symptoms or progression, possibly through its interaction with cellular pathways implicated in such disorders.
Overall, 1-(2-methoxy-ethyl)-5-oxo-pyrrolidine-3-carboxylic acid is a significant chemical entity with a broad spectrum of applications, particularly in the realms of medicinal chemistry and drug development, showcasing its potential to address various unmet needs in healthcare.
Check Digit Verification of cas no
The CAS Registry Mumber 407634-05-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,7,6,3 and 4 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 407634-05:
(8*4)+(7*0)+(6*7)+(5*6)+(4*3)+(3*4)+(2*0)+(1*5)=133
133 % 10 = 3
So 407634-05-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H13NO4/c1-13-3-2-9-5-6(8(11)12)4-7(9)10/h6H,2-5H2,1H3,(H,11,12)
407634-05-3Relevant articles and documents
CYCLIC AMINE BASE-1 INHIBITORS HAVING A HETEROCYCLIC SUBSTITUENT
-
Page/Page column 31, (2008/06/13)
Disclosed are novel compounds of the formula (I)or a pharmaceutically acceptable salt or solvate thereof, wherein R1 is formula (I) X is -0-, -C(R14)2- or -N(R)-; Z is -C(R14)2- or -N(R)-; t is 0, 1, 2 or 3; each R and R2 is independently H, alkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, heterocycloalkylalkyl, alkenyl or alkynyl; each R14 is H, alkyl, alkenyl, alkynyl, halo, -CN, haloalkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, heterocycloalkylalkyl, -OR35, -N(R24)(R25)or -SR35; R41 is alkyl, cycloalkyl, -S02(alkyl), -C(O)-alkyl, -C(O)-cycloalkyl or -alkyl-NH-C(O)CH3; and the remaining variables are as defined in the specification. Also disclosed are pharmaceutical compositions comprising the compounds of formula I and methods of treating cognitive or neurodegenerative diseases with compounds of formula (I). Also disclosed are pharmaceutical compositions and methods of treatment comprising compounds of formula I in combination with other agents useful in treating cognitive or neurodegenerative diseases.
